A Comprehensive Review on Molecular Docking in Drug Discovery

The completion of the human genome project marks a significant breakthrough for human civilization in its attempt to understand the enigmas of nature. This biological study provided a fresh direction to the conventional view on drug design, in specific, the choice of therapeutic targets, where we may consider of the genome as a pharmacological target [1]. These days, it's straightforward to attain these goals with accurate techniques like high throughput protein purification, crystallography, and NMR (Nuclear Magnetic Resonance) spectroscopy. Even for tiny features of molecules and their complexes, the structural details produced by these methods have greatly enhanced human knowledge. This process easily creates huge quantities of data that must be stored methodically and retrieved as required. Robust computational methods are necessary for the storage, organization, and exploration of more than one million high-resolution 3D protein structures. The drug discovery process has been enhanced with approaches including virtual screening, lead identification, and optimization generated via computational models [2, 3]. Since its inception in the 1960s, docking has demonstrated itself to be a useful instrument and a crucial strategy in drug screening, protein-protein interactions, and nanomaterial behavior. That's owing to the incredible developments in physics, chemistry, information technology, biochemistry, and computers. Technologies that dock tiny compounds into macromolecules, especially protein targets, dominate the modern area of computer-aided drug design (CADD), and their application is growing constantly. Structure-based medicines design nowadays CADD is vital [4–7], and this department is present in the majority of large pharmaceutical corporations. Many pharmaceuticals sold in stores are directly created using the CADD approach [8]. It is certain that docking approaches are essential advances in science for grasping chemical molecules, particularly considering the fact that three eminent computational scientists received the 2013 Chemistry Nobel Prize. Protein–ligand, referred to as protein–protein docking, is an algorithmic approach that anticipates a ligand's orientation upon docking to an enzyme or protein receptor. Most of the time, one can select the most potent ligand for future biochemistry research and development based on its "binding affinity. “Due to the ease of use and minimal equipment needed (it even functions well on a Computer), docking Over the past ten years, the number of linked studies has greatly risen. A comprehensive examination reveals that accuracy is an important concern with docking investigation, as these articles will be of little benefit if the docking is not done precisely. The accuracy of docking can occasionally even fluctuate between 0% and 92.66%. [9] The field of docking between molecules faces barriers that must be dealt with in order to boost predictive capacity and expand the computational field's utilize.  Docking has shown remarkable development as a field of study since its inception. The underlying algorithms do not always predict the proper binding modes of a ligand because they merely reflect approximations of the real world. As a result, the docking score ranks the various docked positions that are produced by each docking run in a sequential manner. Only specific characteristics—such as tiny ligands, sufficient to occupy the binding site, receptor knowledge, a lower threshold for binding locations, and—above all—expert handling—can accurately predict the binding modes [10].  The development of drugs and design depend heavily on molecular docking, a computer algorithm that predicts the optimal orientation of small molecules once they are bound to target proteins. This process aids in understanding the interactions between chemicals and proteins, which facilitates the development of new treatment medicines. The history of molecular docking began in the 1980s, when algorithmic advancements persisted. Boost processing power to increase accuracy and efficiency. These days, a fundamental tool in pharmaceutical research is molecular docking, allowing the recognition of interesting drug candidates and the optimization of their interactions during binding. The relevance and development of molecular docking in drug discovery is briefly outlined in this text [11]. In order to find possible binding sites and improve the medication's binding affinity and specificity, researchers can use it to model and examine the connections among the proposed drug and the protein of interest. A useful technique for screening sizable chemical libraries and forecasting their potential as therapeutic candidates is molecular docking. However, manual drug study employs more conventional methods in which researchers can model and examine the binding between the drug candidate and the target protein, assisting in the identification of possible binding sites and the improvement of the drug's binding specificity and affinity. Molecular docking is a useful tool for a useful method for evaluating sizable chemical libraries and forecasting their potential as therapeutic candidates is docking [12]. Experiments like crystallography and biochemical assays are frequently used in this procedure to comprehend the binding mechanisms and maximize the drug's effectiveness. Manual drug study offers more thorough and precise information regarding drug-target interactions, even if molecular docking is a quicker and more economical method of screening and analyzing possible drug candidates [13]. The choice between molecular docking and manual drug study ultimately depends on the particular research goals, available resources, and the complexity of the drug-target interactions being studied.

The basic theory of molecular docking

Figure 1: Two models of molecular docking. (A) A lock-and-key model. (B) Induced fit model.

In order to predict and determine the binding affinity with interaction form among ligands and receptor is molecular docking models a desired conformation based on complementarity and pre-planning [14]. Figure 1A illustrates the first suggested "lock-and-key model," which calls for the rigorous docking of ligands and receptors to ascertain the ideal orientation for the "key" that will open the "lock." The importance of geometric complementarity is demonstrated by this model. [15]